John R. Thomas

Professor of Law

B.S., Carnegie Mellon; J.D., University of Michigan; LL.M., George Washington

Areas of Expertise:

Contracts, Intellectual Property, Patent

Professor Thomas joined the Law Center faculty in 2002. He has served as a Visiting Scholar at the Congressional Research Service for the past decade...

Continue Reading

Professor Thomas joined the Law Center faculty in 2002. He has served as a Visiting Scholar at the Congressional Research Service for the past decade and was named the inaugural Thomas Alva Edison Visiting Scholar at the U.S. Patent and Trademark Office in 2011. He previously was a member of the faculty of the George Washington University Law School, and has served on the visiting faculties at
Cornell Law School and the University of Tokyo. Professor Thomas formerly served as law clerk to Chief Judge Helen W. Nies of the U.S. Court of Appeals for the Federal Circuit; visiting fellow at the Max Planck Institute for Foreign and Comparative Patent, Copyright and Unfair Competition Law in Munich,
Germany; and research scholar at the Institute of Intellectual Property in Tokyo, Japan. Professor Thomas has published numerous articles and six books on the subject of intellectual property law.



 

Recent Scholarship

Books

  • John R. Thomas, Pharmaceutical Patent Law (Arlington, Va.: Bloomberg BNA 3d ed. 2015).    [BOOK]

Contributions to Law Reviews and Other Scholarly Journals

  • John R. Thomas, The End of "Patent Medicines"? Thoughts on the Rise of Regulatory Exclusivities, 70 Food & Drug L.J. 39-53 (2015).    [HEIN] [W]

Book Chapters and Collected Works

  • John R. Thomas, Toward a Theory of Regulatory Exclusivities, in Patent Law in Global Perspective 345-376 (Ruth L. Okediji & Margo A. Bagley eds., New York: Oxford University Press 2014).    [BOOK]
  • John R. Thomas, Authorized Generic Pharmaceuticals: Effects on Innovation, in Pharmaceutical Industry: Innovation and Developments 1-14 (David A. Mancuso & Isobel M. Grenada eds., Hauppauge, N.Y.: Nova Science Publishers 2011).    [BOOK]
View all scholarship

All Scholarship 2001 - Present

Books

  • John R. Thomas, Pharmaceutical Patent Law (Arlington, Va.: Bloomberg BNA 3d ed. 2015).    [BOOK]
  • John R. Thomas, Pharmaceutical Patent Law (Arlington, Va.: Bureau of National Affairs 2d ed. 2010).   
  • John R. Thomas & Roger E. Schechter, Principles of Copyright Law (St. Paul, Minn.: West 2010).    [BOOK]
  • John R. Thomas, Martin J. Adelman & Randall R. Rader, Cases and Materials on Patent Law (St. Paul, Minn.: West 3d ed. 2009).    [BOOK]
  • John R. Thomas, Intellectual Property and the Free Trade Agreements: Information Policy Issues (Wash., D.C.: Congressional Research Service 2005).   
  • John R. Thomas, Pharmaceutical Patent Law (Wash., D.C.: Bureau of National Affairs 2005 & Supp. 2006).    [BOOK]
  • John R. Thomas & Roger E. Schechter, Principles of Patent Law (St. Paul, Minn.: Thomson/West 2004).   
  • John R. Thomas, Martin J. Adelman, Randall R. Rader & Harold C. Wegner, Cases and Materials on Patent Law (St. Paul, Minn.: Thomson/West 2d ed. 2003).    [BOOK]
  • John R. Thomas & Roger E. Schechter, Intellectual Property: The Law of Copyrights, Patents, and Trademarks (St. Paul, Minn.: Thomson/West 2003).    [BOOK]

Contributions to Law Reviews and Other Scholarly Journals

  • John R. Thomas, The End of "Patent Medicines"? Thoughts on the Rise of Regulatory Exclusivities, 70 Food & Drug L.J. 39-53 (2015).    [HEIN] [W]
  • John R. Thomas, Statutory Subject Matter in Context: Lessons in Patent Governance from Bilski v. Kappos, 15 Lewis & Clark L. Rev. 133-151 (2011).    [HEIN] [W]
  • John R. Thomas, David J. Kappos & Randall J. Bluestone, A Technological Contribution Requirement for Patentable Subject Matter: Supreme Court Precedent and Policy, 6 Nw. J. Tech. & Intell. Prop. 152-170 (2008).    [HEIN] [W]
  • John R. Thomas, John Richards, Herbert F. Schwartz & Steven J. Lee, Panel I: KSR v. Teleflex: The Nonobviousness Requirement of Patentability, 17 Fordham Intell. Prop. Media & Ent. L.J. 875-932 (2007).    [HEIN] [W] [Gtown Law]
  • John R. Thomas, Academics and the Federal Circuit: Is There a Gulf and How Do We Bridge it?, 15 Fed. Cir. B.J. 315-319 (2005).    [HEIN] [W] [Gtown Law]
  • John R. Thomas, Claim Re-Construction: The Doctrine of Equivalents in the Post-Markman Era, 9 Lewis & Clark L. Rev. 153-175 (2005).    [HEIN] [W] [Gtown Law]
  • John R. Thomas, Formalism at the Federal Circuit, 52 Am. U. L. Rev. 771-810 (2003).    [HEIN] [W]
  • John R. Thomas, The Responsibility of the Rulemaker: Comparative Approaches to Patent Administration Reform, 17 Berkeley Tech. L.J. 727-761 (2002).    [HEIN] [W] [Gtown Law]
  • John R. Thomas, Liberty and Property in the Patent Law, 39 Hous. L. Rev. 569-619 (2002).    [HEIN] [W] [Gtown Law]
  • John R. Thomas, Collusion and Collective Action in the Patent System: A Proposal for Patent Bounties, 2001 U. Ill. L. Rev. 305-353 (2001).    [HEIN] [W] [Gtown Law]

Book Chapters and Collected Works

  • John R. Thomas, Toward a Theory of Regulatory Exclusivities, in Patent Law in Global Perspective 345-376 (Ruth L. Okediji & Margo A. Bagley eds., New York: Oxford University Press 2014).    [BOOK]
  • John R. Thomas, Authorized Generic Pharmaceuticals: Effects on Innovation, in Pharmaceutical Industry: Innovation and Developments 1-14 (David A. Mancuso & Isobel M. Grenada eds., Hauppauge, N.Y.: Nova Science Publishers 2011).    [BOOK]
  • John R. Thomas, Patent Governance in the United States: Lessons from Bilski v. Kappos, in Biotechnology and Software Patent Law: A Comparative Review of New Developments 193-218 (Emanuela Arezzo & Gustavo Ghidini eds., Cheltenham, U.K.: Edward Elgar 2011).    [BOOK]
  • John R. Thomas, Pharmaceutical Patent Litigation Settlements: Implications for Competition and Innovation, in Pharmaceutical Industry: Innovation and Developments 127-146 (David A. Mancuso & Isobel M. Grenada eds., Hauppauge, N.Y.: Nova Science Publishers 2011).    [BOOK]
  • John R. Thomas, Challenges to the Sui Generis Regime of Pharmaceutical Patents, in Patent Law and Theory: A Handbook of Contemporary Research 645-672 (Toshiko Takenaka ed., Northampton, Mass.: Edward Elgar 2008).   
  • John R. Thomas, The Story of Graver Tank v. Linde: Intellectual Property Infringement in Flux, in Intellectual Property Stories 298-326 (Jane C. Ginsburg & Rochelle Cooper Dreyfuss eds., New York: Foundation Press 2006).    [BOOK]
  • John R. Thomas, An Examination of the Issues Surrounding Biotechnology Patenting and its Effect upon Entrepreneurial Companies, in Patents: Issues and Legal Developments 181-206 (John V. Martin ed., Hauppauge, N.Y.: Nova Science Publishers 2002).    [BOOK]
  • John R. Thomas, Multinational Patent Acquisition and Enforcement: Public Policy Challenges and Opportunities for Innovative Firms, in Patents: Issues and Legal Developments 143-180 (John V. Martin ed., Hauppauge, N.Y.: Nova Science Publishers 2002).    [BOOK]
  • John R. Thomas & Wendy H. Schacht, Patent Law and its Application to the Pharmaceutical Industry: An Examination of the Drug Price Composition and Patent Term Restoration Act of 1984, in Patents: Issues and Legal Developments 107-142 (John V. Martin ed., Hauppauge, N.Y.: Nova Science Publishers 2002).    [BOOK]
  • John R. Thomas, Patent Law Reform: An Analysis of the American Inventors Protection Act of 1999 and its Effect on Small, Entrepreneurial Firms, in Patents: Issues and Legal Developments 83-106 (John V. Martin ed., Hauppauge, N.Y.: Nova Science Publishers 2002).    [BOOK]
  • John R. Thomas, Patents on Methods of Doing Business, in Patents: Issues and Legal Developments 33-60 (John V. Martin ed., Hauppauge, N.Y.: Nova Science Publishers 2002).    [BOOK]
  • John R. Thomas & Wendy H. Schacht, Pharmaceutical Patent Term Extensions: A Brief Explanation, in Patents: Issues and Legal Developments 13-18 (John V. Martin ed., Hauppauge, N.Y.: Nova Science Publishers 2002).    [BOOK]
  • John R. Thomas & Wendy H. Schacht, Stem Cell Research and Patents: An Introduction to the Issues, in Patents: Issues and Legal Developments 19-32 (John V. Martin ed., Hauppauge, N.Y.: Nova Science Publishers 2002).    [BOOK]

U.S. Supreme Court Briefs

  • Brief of Intellectual Property Law Professors as Amici Curiae Supporting Petitioner, KSR International Co. v. Teleflex Inc., No. 04-1350 (U.S. Aug. 26, 2006).    [W] [Gtown Law]
  • Brief of International Business Machines Corporation as Amicus Curiae Supporting Neither Party, Laboratory Corporation of America Holdings v. Metabolite Laboratories Inc., No. 04-607 (U.S. Dec. 15, 2005).    [W] [Gtown Law]
  • Brief of Intellectual Property Law Professors as Amici Curiae Supporting Petitioner, Eli Lilly and Co. v. Barr Laboratories, Inc., No. 01-660 (U.S. Dec. 11, 2001).    [W]

Congressional Testimony

  • Patent Reform Implementation and New Challenges for Small Businesses: Hearing Before the H. Comm. on Small Bus., 113th Cong., May 15, 2013 (Statement of John R. Thomas) (CIS-No.: 2014-H721-11).    [WWW]
  • Patent Reform Act of 2009: Hearing Before the H. Comm. on the Judiciary, 111th Cong., Apr. 30, 2009 (Statement of John R. Thomas) (CIS-No.: 2011-H521-7).    [Gtown Law] [WWW]
  • Full Committee Hearing on the Importance of Patent Reform on Small Business: Hearing Before the H. Comm'n on Small Bus., 110th Cong., Mar. 29, 2007 (Statement of John R. Thomas) (CIS-No.: 2008-H721-8).    [Gtown Law]
  • Process Patents: Hearing Before the S. Comm. on the Judiciary, 110th Cong., May 1, 2007 (Statement of John R. Thomas) (CIS-No.: 2007-S521-61).    [Gtown Law]
  • The Patent Reform Act of 2007: Hearing Before the Subcomm. on Courts, the Internet, & Intellectual Prop. of the H. Comm. on the Judiciary, 110th Cong., April 26, 2007 (Statement of John R. Thomas) (CIS-No.: 2008-H521-15).    [Gtown Law]
  • Bill To Amend Title 35, U.S. Code, To Conform Certain Filing Provisions Within the Patent and Trademark Office, 109th Cong., Sept. 14, 2006 (Statement of John R. Thomas) CIS-No.: 2006-H521-101.    [Gtown Law]
  • Perspectives on Patents: Post-Grant Review Procedures and Other Litigation Reforms: Hearing Before the Subcomm. on Intellectual Prop. of the S. Comm. on the Judiciary, 109th Cong., May 23, 2006 (Statement of John R. Thomas) (CIS-No.: 2007-S521-52).    [Gtown Law]
  • Amendment in the Nature of a Substitute to H.R. 2795, the "Patent Act of 2005": Hearing Before the Subcomm. on Courts, the Internet & Intellectual Prop. of the H. Comm. on the Judiciary, 109th Cong., Sept. 15, 2005 (Statement of John R. Thomas) (CIS-No.: 2005-H521-64.    [Gtown Law]
  • Cooperative Research and Technology Enhancement (CREATE) Act of 2003: Hearing on H. R. 2390 Before the H. Subcomm. on Courts, the Internet & Intellectual Prop. of the H. Comm. on the Judiciary, 108th Cong., June 10, 2003 (Statement of John R. Thomas) (CIS-No.: 2003-H521-40).    [Gtown Law]
  • Patent Quality Improvement: Hearing Before H. Subcomm. on Courts, the Internet, & Intellectual Prop. of the H. Comm. on the Judiciary, 108th Cong., July 24, 2003 (Statement of John R. Thomas) (CIS-No.: 2003-H521-49).    [Gtown Law]

Selected Contributions to Other Publications

  • John R. Thomas, Highlights of Qualified Retirement Plan Changes Under EGTRRA, 13 S.C. Law. 13-18 (2002).    [HEIN] [W]
Recent scholarship

In the News

"The importance of PTAB patent review proceedings for addressing low quality patents," coverage by IP Watchdog, June 26, 2016, mentioning Professor John Thomas.

"Judge Michel says Congress stuck in a time warp on patent reform," coverage in IP Watchdog, May 12, 2015, featuring Professor John Thomas.

Professor John R. Thomas testified about patent reform implementation and new challenges for small businesses before the House Committee on Small Business, May 15, 2013.

All News

"The importance of PTAB patent review proceedings for addressing low quality patents," coverage by IP Watchdog, June 26, 2016, mentioning Professor John Thomas.

"Judge Michel says Congress stuck in a time warp on patent reform," coverage in IP Watchdog, May 12, 2015, featuring Professor John Thomas.

Professor John R. Thomas testified about patent reform implementation and new challenges for small businesses before the House Committee on Small Business, May 15, 2013.

Recent News